MX2018002644A - Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3 -ona sustituidos. - Google Patents

Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3 -ona sustituidos.

Info

Publication number
MX2018002644A
MX2018002644A MX2018002644A MX2018002644A MX2018002644A MX 2018002644 A MX2018002644 A MX 2018002644A MX 2018002644 A MX2018002644 A MX 2018002644A MX 2018002644 A MX2018002644 A MX 2018002644A MX 2018002644 A MX2018002644 A MX 2018002644A
Authority
MX
Mexico
Prior art keywords
pyrrolo
imidazol
dihydro
substituted
antibacterial compounds
Prior art date
Application number
MX2018002644A
Other languages
English (en)
Spanish (es)
Inventor
Schmitt Christine
Panchaud Philippe
Mirre Azely
Catherine Blumstein Anne-
Mathieu Gaelle
JACOB Loïc
Masse Florence
Luc Specklin Jean-
Surivet Jean-Philippe
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of MX2018002644A publication Critical patent/MX2018002644A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2018002644A 2015-09-03 2016-09-02 Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3 -ona sustituidos. MX2018002644A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2015070144 2015-09-03
PCT/EP2016/070695 WO2017037221A1 (en) 2015-09-03 2016-09-02 Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds

Publications (1)

Publication Number Publication Date
MX2018002644A true MX2018002644A (es) 2018-06-20

Family

ID=56852279

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018002644A MX2018002644A (es) 2015-09-03 2016-09-02 Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3 -ona sustituidos.

Country Status (17)

Country Link
US (1) US10314823B2 (https=)
EP (1) EP3344630B1 (https=)
JP (1) JP2018526391A (https=)
KR (1) KR20180049017A (https=)
CN (1) CN108137596A (https=)
AR (1) AR105889A1 (https=)
AU (1) AU2016313794B2 (https=)
BR (1) BR112018004343A2 (https=)
CA (1) CA2994996A1 (https=)
CL (1) CL2018000533A1 (https=)
EA (1) EA201890626A1 (https=)
HK (1) HK1256614A1 (https=)
IL (1) IL257757A (https=)
MX (1) MX2018002644A (https=)
PH (1) PH12018500323A1 (https=)
TW (1) TW201714885A (https=)
WO (1) WO2017037221A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
TW201840569A (zh) * 2017-03-01 2018-11-16 瑞士商愛杜西亞製藥有限公司 (2r)-n-羥基-4-(6-((1-(2-羥基乙基)氮雜環丁烷-3-基)丁-1,3-二炔-1-基)-3-氧基-1h-吡咯并[1,2-c]咪唑-2(3h)-基)-2-甲基-2-(甲磺醯基)丁醯胺之結晶形式
WO2018224455A1 (en) 2017-06-07 2018-12-13 Basf Se Substituted cyclopropyl derivatives
WO2019038362A1 (en) 2017-08-24 2019-02-28 Idorsia Pharmaceuticals Ltd ANTIBACTERIAL PYRROLOIMIDAZOLONES
WO2019086452A1 (en) 2017-10-31 2019-05-09 Idorsia Pharmaceuticals Ltd Antibacterial heteroaromatic compounds
WO2019121143A1 (en) 2017-12-20 2019-06-27 Basf Se Substituted cyclopropyl derivatives
JP7156199B2 (ja) * 2018-08-09 2022-10-19 信越化学工業株式会社 レジスト材料及びパターン形成方法
CA3141826A1 (en) 2019-05-31 2020-12-03 Ikena Oncology, Inc. Tead inhibitors and uses thereof
CA3142351A1 (en) 2019-05-31 2020-12-03 Ikena Oncology, Inc. Tead inhibitors and uses thereof
AU2020388645B2 (en) * 2019-11-21 2026-03-19 University Of Utah Research Foundation TRPV4 receptor ligands

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100984595B1 (ko) 2002-03-13 2010-09-30 어레이 바이오파마 인크. Mek 억제제로서의 n3 알킬화 벤즈이미다졸 유도체
UA80500C2 (en) 2003-10-17 2007-09-25 Basf Ag Fungicidal mixture and agent for controlling rice pathogens, containing triazolopyrimidine derivative and metalaxyl-m, method for controlling rice pathogens and sowing material
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
WO2011045703A2 (en) 2009-10-13 2011-04-21 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
WO2011073845A1 (en) 2009-12-16 2011-06-23 Pfizer Inc. N-linked hydroxamic acid derivatives useful as antibacterial agents
CN103328482A (zh) 2011-01-03 2013-09-25 韩美药品株式会社 用于调节g蛋白-偶联受体的新双环化合物
ES2626457T3 (es) 2011-03-07 2017-07-25 Pfizer Inc. Derivados de fluoro-piridinona útiles como agentes antibacterianos
CA2830866A1 (en) 2011-04-08 2012-10-11 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
ES2526687T3 (es) 2011-04-08 2015-01-14 Pfizer Inc. Derivados de isoxazol útiles como agentes antibacterianos
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
CA2891569A1 (en) 2012-11-16 2014-05-22 Bristol-Myers Squibb Company Pyrrolidine gpr40 modulators
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
WO2015066413A1 (en) 2013-11-01 2015-05-07 Novartis Ag Oxazolidinone hydroxamic acid compounds for the treatment of bacterial infections
EA030730B1 (ru) 2013-12-19 2018-09-28 Идорсиа Фармасьютиклз Лтд Антибактериальные производные 1h-индазола и 1h-индола
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
CA2948077A1 (en) 2014-05-16 2015-11-19 Actelion Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
KR20170086079A (ko) 2014-11-19 2017-07-25 액테리온 파마슈티칼 리미티드 항균성 벤조티아졸 유도체
AR105646A1 (es) * 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
CA2991281A1 (en) 2015-08-28 2017-03-09 Idorsia Pharmaceuticals Ltd Antibacterial annulated pyrrolidin-2-one derivatives
AR105848A1 (es) 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
EP3386950A1 (en) 2015-12-08 2018-10-17 GlaxoSmithKline Intellectual Property Development Limited Substituted benzazinones as antibacterial compounds
WO2017198647A1 (en) 2016-05-17 2017-11-23 Idorsia Pharmaceuticals Ltd 6-(buta-1,3-diyn-1-yl)benzo[d]thiazole derivatives

Also Published As

Publication number Publication date
WO2017037221A1 (en) 2017-03-09
BR112018004343A2 (pt) 2018-09-25
CL2018000533A1 (es) 2018-06-29
CA2994996A1 (en) 2017-03-09
TW201714885A (zh) 2017-05-01
AU2016313794A1 (en) 2018-04-19
EA201890626A1 (ru) 2018-09-28
EP3344630B1 (en) 2020-12-09
PH12018500323A1 (en) 2018-08-13
HK1256614A1 (zh) 2019-09-27
AR105889A1 (es) 2017-11-22
US20180250273A1 (en) 2018-09-06
KR20180049017A (ko) 2018-05-10
AU2016313794B2 (en) 2020-06-04
JP2018526391A (ja) 2018-09-13
EP3344630A1 (en) 2018-07-11
US10314823B2 (en) 2019-06-11
CN108137596A (zh) 2018-06-08
IL257757A (en) 2018-04-30

Similar Documents

Publication Publication Date Title
PH12018500323A1 (en) Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds
TN2018000276A1 (en) Inhibitors of receptor-interacting protein kinase 1.
MX380239B (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona.
EA201691913A1 (ru) Замещенные [1,2,4]триазольные и имидазольные соединения в качестве фунгицидов
MX378288B (es) Inhibidores de pirimidina del fgfr4.
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
PH12016500643A1 (en) New octahydro - cyclobuta [1,2-c;3,4-c`] dipyrrol -2- yl
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
HK1217492A1 (zh) 作爲刺猬信号通路抑制剂的杂环化合物
EA201691272A1 (ru) Тетрагидропиридопиразины в качестве модуляторов gpr6
EA201692521A1 (ru) Пиразольные соединения и их применение в качестве блокаторов кальциевых каналов т-типа
MX2016005760A (es) Inhibidores de glucogeno sintasa cinasa 3 (gsk-3).
EA201692525A1 (ru) Замещенные соединения [1,2,4]триазола и имидазола в качестве фунгицидов
PH12018500301A1 (en) Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterials
EA201691775A1 (ru) Производные 1,2-дигидро-3н-пирроло[1,2-с]имидазол-3-она и их применение в качестве антибактериальных средств
PH12016500347A1 (en) Triazolopyridine compounds, compositions and methods of use thereof
EA201692289A1 (ru) Замещенные [1,2,4]триазольные и имидазольные соединения в качестве фунгицидов
EA201690716A1 (ru) ПИРИДО[2,3-d]ПИРИМИДИН-4-ОНОВЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ТАНКИРАЗЫ
MX2017007380A (es) Compuestos organicos.
WO2016014864A8 (en) Hydroxy-(r),(r)-2,2'-bismethylnaltrexones and uses thereof
EA201892585A1 (ru) 6-(БУТА-1,3-ДИИН-1-ИЛ)БЕНЗО[d]ТИАЗОЛЬНЫЕ ПРОИЗВОДНЫЕ
WO2016023522A3 (en) Substituted phosphoramidate compounds and uses thereof
EA201700037A1 (ru) Производные 2н-хромена в качестве анальгезирующих средств